AVBP

Conviction 49HealthcareScan · Thu, Sep 24, 2026

Dragonfly doji

ArriVent BioPharma, Inc. (AVBP) closed at $30.12 (-0.61%) on Sep 24, 2026. Its latest daily candle is a dragonfly doji. Price is above its 50-day and above its 200-day moving average. RSI(14) 53, RS Rating 87, -13.3% from its 52-week high, +44.8% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

AVBP$30.12-0.61%

ResistanceSupportVol 14

Vol MA14 628.49K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

ArriVent BioPharma, Inc.PHARMACEUTICAL PREPARATIONSwww.arrivent.com ↗

Price30.12

Change-0.61%

Gap-0.79%

Rel volume0.79×

Avg volume553.36K

Avg $ vol16.37M

SMA 2029.68

SMA 5030.11

SMA 20027.18

Price vs 50+0.02%

Price vs 200+10.78%

MA stackbullish

50/200 cross—

Supertrenddown · 31.62

RSI (14)53

MACD hist0.17

MACD crossbull · 2d

Stoch %K / %D67 / 71

ADX (14)13

+DI / −DI26 / 18

RSI divergence—

MACD divergence—

ATR %4.61%

ADR %4.23%

52w high34.74

52w low17.17

From 52w high-13.31%

Above 52w low+75.39%

New 52w highNo

SqueezeOn · 1d

Bollinger width13.44%

%B0.61

Donchian pos63.21%

Donchian high31.77

Donchian low27.28

AVWAP (52w high)31.02

vs AVWAP high-2.92%

AVWAP (52w low)27.00

vs AVWAP low+11.54%

OBV trendFlat

Chaikin MF (20)-0.06

Today vs 20d0.79×

Avg vol (14d)628.49K

Avg vol (20d)553.36K

Avg $ vol (20d)16.37M

Market cap1.48B

RS Rating87 / 99

RS 3m (vs SPY)-15.46%

RS 6m (vs SPY)+15.56%

RS line new highNo

Trend template7/8

Technical rank77.4

1 week+6.19%

1 month-3.94%

3 months-10.97%

6 months+32.37%

1 year+64.83%

YTD+44.78%

P/E-8.93

P/B4.05

P/S—

P/FCF—

EPS-4.32

Div yield—

ROE-45.34%

ROA-42.13%

Debt/Eq—

Current14.16

EV/EBITDA-7.37

Gross margin—

Net margin—

Rev growth—

EPS growth-106.62%

Price target44.57

Target upside48.00%

Analyst ratingBuy

Institutional97.40%

Ent. value1.33B

Revenue—

Net income-49.89M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out46.57M

Employees77

ListedFri, Jan 26, 2024

Free float21.68M

Float %52.5%

Short interest8.69M

Days to cover20.4d

Short volume82.7%

Squeeze score85 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.05 vs −$0.98

Last surprise-7.1% miss

Setup gradeC

Conviction49 / 100

Pattern quality—

Tech rank77.4 / 100

Group rank59 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmDragonfly doji

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AVBP

All disclosures →

No recent disclosed trades by Congress in AVBP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AVBP

Insider	Side	Shares	Value	Traded	Filed
Nolet Chris Director · Non-Qualified Stock Option (right to buy) · 2026-06-18	Grant	13.56K	—	2026-06-18	2026-06-22
Hohneker John Director · Non-Qualified Stock Option (right to buy) · 2026-06-18	Grant	13.56K	—	2026-06-18	2026-06-22
Peterson Kristine Director · Non-Qualified Stock Option (right to buy) · 2026-06-18	Grant	13.56K	—	2026-06-18	2026-06-22
Parsey Merdad Director · Non-Qualified Stock Option (right to buy) · 2026-06-18	Grant	13.56K	—	2026-06-18	2026-06-22

SEC filings

EDGAR filings in AVBP · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

AVBP

Recent news

Get daily signals & real-time alerts.